Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cervical cancer vaccine
Biotech
Investors flip-flop on Nykode's cancer vaccine data drop
Nykode trumpeted midphase results linking its cervical cancer vaccine to partial and complete responses in heavily pretreated patients.
Nick Paul Taylor
May 9, 2022 8:50am
Novel immunotherapy prevents cervical, lung cancer in mice
Feb 15, 2019 9:55am
Advaxis suffers another blow as FDA puts phase 3 on partial hold
Jan 24, 2019 7:35am
Cancer vaccine startup Oxford Vacmedix taps Asian syndicate for series A
Mar 7, 2018 9:10am
